Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.

Identifieur interne : 000556 ( Main/Exploration ); précédent : 000555; suivant : 000557

Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.

Auteurs : Julia L M. Dunn [États-Unis] ; Laurel B. Kartchner [États-Unis] ; Karli Gast [États-Unis] ; Marci Sessions [États-Unis] ; Rebecca A. Hunter [États-Unis] ; Lance Thurlow [États-Unis] ; Anthony Richardson [États-Unis] ; Mark Schoenfisch [États-Unis] ; Bruce A. Cairns [États-Unis] ; Robert Maile [États-Unis]

Source :

RBID : pubmed:29393976

Descripteurs français

English descriptors

Abstract

Bacterial pneumonia is a leading cause of death late after burn injury due to the severe immune dysfunction that follows this traumatic injury. The Mechanistic/Mammalian Target of Rapamycin (mTOR) pathway drives many effector functions of innate immune cells required for bacterial clearance. Studies have demonstrated alterations in multiple cellular processes in patients and animal models following burn injury in which mTOR is a central component. Goals of this study were to (1) investigate the importance of mTOR signaling in antimicrobial activity by neutrophils and (2) therapeutically target mTOR to promote normalization of the immune response. We utilized a murine model of 20% total body surface area burn and the mTOR-specific inhibitor rapamycin. Burn injury led to innate immune hyperresponsiveness in the lung including recruitment of neutrophils with greater ex vivo oxidative activity compared with neutrophils from sham-injured mice. Elevated oxidative function correlated with improved clearance of Pseudomonas aeruginosa, despite down-regulated expression of the bacterial-sensing TLR molecules. Rapamycin administration reversed the burn injury-induced lung innate immune hyperresponsiveness and inhibited enhanced bacterial clearance in burn mice compared with untreated burn mice, resulting in significantly higher mortality. Neutrophil ex vivo oxidative burst was decreased by rapamycin treatment. These data indicate that (1) neutrophil function within the lung is more important than recruitment for bacterial clearance following burn injury and (2) mTOR inhibition significantly impacts innate immune hyperresponsiveness, including neutrophil effector function, allowing normalization of the immune response late after burn injury.

DOI: 10.1002/JLB.3AB0616-251RRR
PubMed: 29393976
PubMed Central: PMC6181446


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.</title>
<author>
<name sortKey="Dunn, Julia L M" sort="Dunn, Julia L M" uniqKey="Dunn J" first="Julia L M" last="Dunn">Julia L M. Dunn</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Kartchner, Laurel B" sort="Kartchner, Laurel B" uniqKey="Kartchner L" first="Laurel B" last="Kartchner">Laurel B. Kartchner</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Gast, Karli" sort="Gast, Karli" uniqKey="Gast K" first="Karli" last="Gast">Karli Gast</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Sessions, Marci" sort="Sessions, Marci" uniqKey="Sessions M" first="Marci" last="Sessions">Marci Sessions</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Hunter, Rebecca A" sort="Hunter, Rebecca A" uniqKey="Hunter R" first="Rebecca A" last="Hunter">Rebecca A. Hunter</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Thurlow, Lance" sort="Thurlow, Lance" uniqKey="Thurlow L" first="Lance" last="Thurlow">Lance Thurlow</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Richardson, Anthony" sort="Richardson, Anthony" uniqKey="Richardson A" first="Anthony" last="Richardson">Anthony Richardson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Schoenfisch, Mark" sort="Schoenfisch, Mark" uniqKey="Schoenfisch M" first="Mark" last="Schoenfisch">Mark Schoenfisch</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Cairns, Bruce A" sort="Cairns, Bruce A" uniqKey="Cairns B" first="Bruce A" last="Cairns">Bruce A. Cairns</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Maile, Robert" sort="Maile, Robert" uniqKey="Maile R" first="Robert" last="Maile">Robert Maile</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29393976</idno>
<idno type="pmid">29393976</idno>
<idno type="doi">10.1002/JLB.3AB0616-251RRR</idno>
<idno type="pmc">PMC6181446</idno>
<idno type="wicri:Area/Main/Corpus">000623</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000623</idno>
<idno type="wicri:Area/Main/Curation">000623</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000623</idno>
<idno type="wicri:Area/Main/Exploration">000623</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.</title>
<author>
<name sortKey="Dunn, Julia L M" sort="Dunn, Julia L M" uniqKey="Dunn J" first="Julia L M" last="Dunn">Julia L M. Dunn</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Kartchner, Laurel B" sort="Kartchner, Laurel B" uniqKey="Kartchner L" first="Laurel B" last="Kartchner">Laurel B. Kartchner</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Gast, Karli" sort="Gast, Karli" uniqKey="Gast K" first="Karli" last="Gast">Karli Gast</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Sessions, Marci" sort="Sessions, Marci" uniqKey="Sessions M" first="Marci" last="Sessions">Marci Sessions</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Hunter, Rebecca A" sort="Hunter, Rebecca A" uniqKey="Hunter R" first="Rebecca A" last="Hunter">Rebecca A. Hunter</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Thurlow, Lance" sort="Thurlow, Lance" uniqKey="Thurlow L" first="Lance" last="Thurlow">Lance Thurlow</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Richardson, Anthony" sort="Richardson, Anthony" uniqKey="Richardson A" first="Anthony" last="Richardson">Anthony Richardson</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Schoenfisch, Mark" sort="Schoenfisch, Mark" uniqKey="Schoenfisch M" first="Mark" last="Schoenfisch">Mark Schoenfisch</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Cairns, Bruce A" sort="Cairns, Bruce A" uniqKey="Cairns B" first="Bruce A" last="Cairns">Bruce A. Cairns</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
<author>
<name sortKey="Maile, Robert" sort="Maile, Robert" uniqKey="Maile R" first="Robert" last="Maile">Robert Maile</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina</wicri:regionArea>
<placeName>
<region type="state">Caroline du Nord</region>
<settlement type="city">Chapel Hill (Caroline du Nord)</settlement>
</placeName>
<orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of leukocyte biology</title>
<idno type="eISSN">1938-3673</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Burns (complications)</term>
<term>Burns (microbiology)</term>
<term>Female (MeSH)</term>
<term>Lung (immunology)</term>
<term>Lung (microbiology)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred C57BL (MeSH)</term>
<term>Neutrophil Infiltration (MeSH)</term>
<term>Neutrophils (immunology)</term>
<term>Neutrophils (microbiology)</term>
<term>Pseudomonas Infections (immunology)</term>
<term>Pseudomonas Infections (microbiology)</term>
<term>Pseudomonas aeruginosa (immunology)</term>
<term>TOR Serine-Threonine Kinases (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Brûlures (complications)</term>
<term>Brûlures (microbiologie)</term>
<term>Femelle (MeSH)</term>
<term>Granulocytes neutrophiles (immunologie)</term>
<term>Granulocytes neutrophiles (microbiologie)</term>
<term>Infections à Pseudomonas (immunologie)</term>
<term>Infections à Pseudomonas (microbiologie)</term>
<term>Infiltration par les neutrophiles (MeSH)</term>
<term>Poumon (immunologie)</term>
<term>Poumon (microbiologie)</term>
<term>Pseudomonas aeruginosa (immunologie)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée C57BL (MeSH)</term>
<term>Sérine-thréonine kinases TOR (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>TOR Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Burns</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Granulocytes neutrophiles</term>
<term>Infections à Pseudomonas</term>
<term>Poumon</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Lung</term>
<term>Neutrophils</term>
<term>Pseudomonas Infections</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Brûlures</term>
<term>Granulocytes neutrophiles</term>
<term>Infections à Pseudomonas</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Burns</term>
<term>Lung</term>
<term>Neutrophils</term>
<term>Pseudomonas Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Brûlures</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Female</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Neutrophil Infiltration</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Femelle</term>
<term>Infiltration par les neutrophiles</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Bacterial pneumonia is a leading cause of death late after burn injury due to the severe immune dysfunction that follows this traumatic injury. The Mechanistic/Mammalian Target of Rapamycin (mTOR) pathway drives many effector functions of innate immune cells required for bacterial clearance. Studies have demonstrated alterations in multiple cellular processes in patients and animal models following burn injury in which mTOR is a central component. Goals of this study were to (1) investigate the importance of mTOR signaling in antimicrobial activity by neutrophils and (2) therapeutically target mTOR to promote normalization of the immune response. We utilized a murine model of 20% total body surface area burn and the mTOR-specific inhibitor rapamycin. Burn injury led to innate immune hyperresponsiveness in the lung including recruitment of neutrophils with greater ex vivo oxidative activity compared with neutrophils from sham-injured mice. Elevated oxidative function correlated with improved clearance of Pseudomonas aeruginosa, despite down-regulated expression of the bacterial-sensing TLR molecules. Rapamycin administration reversed the burn injury-induced lung innate immune hyperresponsiveness and inhibited enhanced bacterial clearance in burn mice compared with untreated burn mice, resulting in significantly higher mortality. Neutrophil ex vivo oxidative burst was decreased by rapamycin treatment. These data indicate that (1) neutrophil function within the lung is more important than recruitment for bacterial clearance following burn injury and (2) mTOR inhibition significantly impacts innate immune hyperresponsiveness, including neutrophil effector function, allowing normalization of the immune response late after burn injury.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29393976</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>04</Month>
<Day>15</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>05</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3673</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>103</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2018</Year>
<Month>05</Month>
</PubDate>
</JournalIssue>
<Title>Journal of leukocyte biology</Title>
<ISOAbbreviation>J Leukoc Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.</ArticleTitle>
<Pagination>
<MedlinePgn>909-918</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/JLB.3AB0616-251RRR</ELocationID>
<Abstract>
<AbstractText>Bacterial pneumonia is a leading cause of death late after burn injury due to the severe immune dysfunction that follows this traumatic injury. The Mechanistic/Mammalian Target of Rapamycin (mTOR) pathway drives many effector functions of innate immune cells required for bacterial clearance. Studies have demonstrated alterations in multiple cellular processes in patients and animal models following burn injury in which mTOR is a central component. Goals of this study were to (1) investigate the importance of mTOR signaling in antimicrobial activity by neutrophils and (2) therapeutically target mTOR to promote normalization of the immune response. We utilized a murine model of 20% total body surface area burn and the mTOR-specific inhibitor rapamycin. Burn injury led to innate immune hyperresponsiveness in the lung including recruitment of neutrophils with greater ex vivo oxidative activity compared with neutrophils from sham-injured mice. Elevated oxidative function correlated with improved clearance of Pseudomonas aeruginosa, despite down-regulated expression of the bacterial-sensing TLR molecules. Rapamycin administration reversed the burn injury-induced lung innate immune hyperresponsiveness and inhibited enhanced bacterial clearance in burn mice compared with untreated burn mice, resulting in significantly higher mortality. Neutrophil ex vivo oxidative burst was decreased by rapamycin treatment. These data indicate that (1) neutrophil function within the lung is more important than recruitment for bacterial clearance following burn injury and (2) mTOR inhibition significantly impacts innate immune hyperresponsiveness, including neutrophil effector function, allowing normalization of the immune response late after burn injury.</AbstractText>
<CopyrightInformation>©2018 Society for Leukocyte Biology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dunn</LastName>
<ForeName>Julia L M</ForeName>
<Initials>JLM</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kartchner</LastName>
<ForeName>Laurel B</ForeName>
<Initials>LB</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gast</LastName>
<ForeName>Karli</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sessions</LastName>
<ForeName>Marci</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hunter</LastName>
<ForeName>Rebecca A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thurlow</LastName>
<ForeName>Lance</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Richardson</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schoenfisch</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cairns</LastName>
<ForeName>Bruce A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maile</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology & Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 CA016086</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 GM076250</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 AI097539</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R42 AI112064</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>02</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Leukoc Biol</MedlineTA>
<NlmUniqueID>8405628</NlmUniqueID>
<ISSNLinking>0741-5400</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="C546843">mTOR protein, mouse</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020556" MajorTopicYN="N">Neutrophil Infiltration</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011552" MajorTopicYN="N">Pseudomonas Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">NO</Keyword>
<Keyword MajorTopicYN="Y">Pseudomonas aeruginosa</Keyword>
<Keyword MajorTopicYN="Y">TLR</Keyword>
<Keyword MajorTopicYN="Y">macrophage</Keyword>
<Keyword MajorTopicYN="Y">reactive oxygen and nitrogen species</Keyword>
<Keyword MajorTopicYN="Y">trauma</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>12</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2018</Year>
<Month>01</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>4</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29393976</ArticleId>
<ArticleId IdType="doi">10.1002/JLB.3AB0616-251RRR</ArticleId>
<ArticleId IdType="pmc">PMC6181446</ArticleId>
<ArticleId IdType="mid">NIHMS933672</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Am J Respir Cell Mol Biol. 2009 Aug;41(2):237-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19131641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 May 17;8(5):e64250</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23691180</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Surg. 2009 Apr;208(4):489-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19476781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Res Clin Pract. 2007 Apr;76(1):44-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16959366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Mol Life Sci. 2014 Sep;71(17):3241-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24714880</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Trauma. 2006 Nov;61(5):1062-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17099510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Trauma. 2006 Aug;61(2):293-8; discussion 298-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16917441</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Shock. 2007 Dec;28(6):684-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17607156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Shock. 2009 Feb;31(2):157-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18650781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2004 Aug 15;18(16):1926-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15314020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nitric Oxide. 1997 Apr;1(2):145-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9701053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2004 Mar;53(3):795-802</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14988266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Burn Care Res. 2012 Sep-Oct;33(5):683-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22961012</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Med. 2008 Sep-Oct;14(9-10):553-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18548133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Immunol. 2016 May 11;7:180</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27242787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Burn Care Res. 2011 Nov-Dec;32(6):583-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21841493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Microbiol. 2013 Oct;15(10):1632-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23834352</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Shock. 2010 Jan;33(1):5-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19503020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Shock. 2005 Feb;23(2):115-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15665725</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2003 May;52(5):1256-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12716761</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(7):e21245</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21789167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Metabolism. 2006 Jun;55(6):811-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16713442</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Burns. 2011 Feb;37(1):86-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20594757</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S421-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16237641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Shock. 2008 Nov;30(5):503-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18391855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Surg Res. 2013 Jan;179(1):e83-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22459295</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabet Med. 2008 Feb;25(2):157-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18290856</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2005 Jan;54(1):85-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15616014</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cytokine. 2009 Jul;47(1):6-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19447045</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2017 Mar 9;168(6):960-976</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28283069</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2005 Mar;288(3):E585-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15536206</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2008 Sep;31(9):1827-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18556339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2006 Jun 1;176(11):6717-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16709831</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Surg. 2010 Jan;210(1):73-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20123335</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2014 Mar 1;192(5):2405-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24470495</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2011 Dec 19;208(13):2581-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22110166</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Jan 15;9(1):e85623</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24454904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Lung Cell Mol Physiol. 2015 May 1;308(9):L855-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25770180</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Burns Trauma. 2013 Nov 01;3(4):180-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24273693</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Trauma. 2008 Apr;64(4):1069-77; discussion 1077-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18404077</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2015 Oct;15(10):599-614</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26403194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Burns. 2016 Nov;42(7):1522-1527</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27268107</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Caroline du Nord</li>
</region>
<settlement>
<li>Chapel Hill (Caroline du Nord)</li>
</settlement>
<orgName>
<li>Université de Caroline du Nord à Chapel Hill</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Caroline du Nord">
<name sortKey="Dunn, Julia L M" sort="Dunn, Julia L M" uniqKey="Dunn J" first="Julia L M" last="Dunn">Julia L M. Dunn</name>
</region>
<name sortKey="Cairns, Bruce A" sort="Cairns, Bruce A" uniqKey="Cairns B" first="Bruce A" last="Cairns">Bruce A. Cairns</name>
<name sortKey="Cairns, Bruce A" sort="Cairns, Bruce A" uniqKey="Cairns B" first="Bruce A" last="Cairns">Bruce A. Cairns</name>
<name sortKey="Gast, Karli" sort="Gast, Karli" uniqKey="Gast K" first="Karli" last="Gast">Karli Gast</name>
<name sortKey="Hunter, Rebecca A" sort="Hunter, Rebecca A" uniqKey="Hunter R" first="Rebecca A" last="Hunter">Rebecca A. Hunter</name>
<name sortKey="Kartchner, Laurel B" sort="Kartchner, Laurel B" uniqKey="Kartchner L" first="Laurel B" last="Kartchner">Laurel B. Kartchner</name>
<name sortKey="Maile, Robert" sort="Maile, Robert" uniqKey="Maile R" first="Robert" last="Maile">Robert Maile</name>
<name sortKey="Maile, Robert" sort="Maile, Robert" uniqKey="Maile R" first="Robert" last="Maile">Robert Maile</name>
<name sortKey="Richardson, Anthony" sort="Richardson, Anthony" uniqKey="Richardson A" first="Anthony" last="Richardson">Anthony Richardson</name>
<name sortKey="Schoenfisch, Mark" sort="Schoenfisch, Mark" uniqKey="Schoenfisch M" first="Mark" last="Schoenfisch">Mark Schoenfisch</name>
<name sortKey="Sessions, Marci" sort="Sessions, Marci" uniqKey="Sessions M" first="Marci" last="Sessions">Marci Sessions</name>
<name sortKey="Thurlow, Lance" sort="Thurlow, Lance" uniqKey="Thurlow L" first="Lance" last="Thurlow">Lance Thurlow</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000556 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000556 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29393976
   |texte=   Mammalian target of rapamycin regulates a hyperresponsive state in pulmonary neutrophils late after burn injury.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29393976" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020